End-of-day quote
Other stock markets
|
||
- USD | - |
10:04am | GSK sells remaining Haleon stake for GBP1.25 billion | AN |
08:13am | GSK raises $1.5 bln from sale of remaining Haleon stake | RE |
Sales 2024 * | 60.41B 4,770B | Sales 2025 * | 62.71B 4,952B | Capitalization | 164B 12,942B |
---|---|---|---|---|---|
Net income 2024 * | 7.78B 614B | Net income 2025 * | 11.29B 891B | EV / Sales 2024 * | 3.67 x |
Net Debt 2024 * | 58.11B 4,589B | Net Debt 2025 * | 49.97B 3,946B | EV / Sales 2025 * | 3.41 x |
P/E ratio 2024 * |
20.1
x | P/E ratio 2025 * |
14.1
x | Employees | - |
Yield 2024 * |
5.78% | Yield 2025 * |
5.88% | Free-Float | 59.05% |
Latest transcript on Pfizer Inc
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 31/12/92 |
David Denton
DFI | Director of Finance/CFO | 59 | 01/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 31/03/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 22/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 26/09/13 |
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.01% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.55% | 239B | |
-3.35% | 209B | |
+10.04% | 209B | |
+9.27% | 169B |